Study to Evaluate the Diagnostic Performance of of MAGENTIQ-COLO During Colonoscopy. (NCT06568523)

🧪 Interventions in This Study

• MAGENTIQ-COLO. (DIAGNOSTIC_TEST)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (5 Sites)

• Johns Hopkins Hospital — Baltimore, Maryland
• Erlanger Health System — Chattanooga, Tennessee
• Assuta — Haifa, Select State
• Hadassah Medical Organization — Jerusalem,
• Erasmus Medical Center — Rotterdam,

📞 Contact the Study Coordinator

Phone: (855) 694-6725

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Screening Colonoscopy clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.